Lysosomal Alpha Glucosidase Market - Size, Share, Outlook, and Forecast till 2026

Lysosomal alpha-glucosidase is an enzyme that is encoded by the GAA gene in humans. It is also called as α-1, 4-glucosidase and acid maltase. Any errors in this gene would lead to glycogen storage disease type II and Pompe disease. Acid alpha-glucosidase essential for the degradation of glycogen to glucose in lysosomes is encoded by this gene. By proteolytic processing, different forms of acid alpha-glucosidase can be obtained. Three transcript variants encoding the same protein have been found for this gene. Lysosomal alpha-glucosidase is used for the treatment of glycogen storage disease and Pompe disease.

Increasing prevalence of diseases such as glycogen storage disease and Pompe disease and increasing number of population are major factors driving growth of lysosomal alpha glucosidase market.

Key Developments in Lysosomal Alpha Glucosidase Market

Key players are adopting various strategies such as mergers, acquisitions, new product launches, expansions, collaborations, partnerships, approvals, and joint ventures to retain its position in the lysosomal alpha glucosidase market. On March 22, 2018, Amicus Therapeutics announced that Japan's Ministry of Health, Labor and Welfare (MHLW) approved the oral small molecule pharmacological chaperone Galafold® capsules for the treatment of Fabry disease.

On February 27, 2018, Amicus Therapeutics launched Healing Beyond Disease™ initiatives to change lives of people living with rare diseases. Moreover, on April 30, 2018, the U.S. Food and Drug Administration (FDA) accepted priority review of cemiplimab for the treatment of patients with metastatic cutaneous squamous cell carcinoma (CSCC) or patients with locally advanced CSCC who are not candidates for surgery.

In June 2017, Sarepta Therapeutics signed a collaboration with Genethon, a non-profit R&D organization dedicated to the development of biotherapies for orphan genetic diseases from research to clinical validation. Furthermore, on April 26, 2018, JCR Pharmaceuticals announced the decision of the company to construct the Second Clinical Trial Material Manufacturing Center.

Some of the key players operating in the lysosomal alpha glucosidase market include Amicus Therapeutics Inc, Audentes Therapeutics Inc, Etubics Corp, Genzyme Corp, greenovation Biotech GmbH, Huons Co Ltd, JCR Pharmaceuticals Co Ltd, Oxyrane Belgium NV, Pharming Group NV, and Sarepta Therapeutics Inc among others.

Global and Chinese Alpha-Cypermethrin Industry, 2017 Market Research Report

Published Date : Oct 2017

The 'Global and Chinese Alpha-Cypermethrin Industry, 2012-2022 Market Research Report' is a professional and in-depth study on the current state of the global Alpha-Cypermethrin industry with a focus on the Chinese market. The report provides key statistics on the market status of the Alpha-Cypermet...

Global and Chinese (R)-(-)-alpha-methoxyphenylacetic acid (CAS 3966-32-3) Industry, 2017 Market Research Report

Published Date : Oct 2017

The 'Global and Chinese (R)-(-)-alpha-methoxyphenylacetic acid Industry, 2012-2022 Market Research Report' is a professional and in-depth study on the current state of the global (R)-(-)-alpha-methoxyphenylacetic acid industry with a focus on the Chinese market. The report provides key statistics on...

Global and Chinese Fungal alpha amylase Industry, 2017 Market Research Report

Published Date : Oct 2017

The 'Global and Chinese Fungal alpha amylase Industry, 2012-2022 Market Research Report' is a professional and in-depth study on the current state of the global Fungal alpha amylase industry with a focus on the Chinese market. The report provides key statistics on the market status of the Fungal alp...

Global and Chinese Beta-Glucosidase Industry, 2017 Market Research Report

Published Date : Oct 2017

The 'Global and Chinese Beta-Glucosidase Industry, 2012-2022 Market Research Report' is a professional and in-depth study on the current state of the global Beta-Glucosidase industry with a focus on the Chinese market. The report provides key statistics on the market status of the Beta-Glucosidase m...

Global and Chinese Alpha-Ketoglutaric Acid Industry, 2017 Market Research Report

Published Date : Oct 2017

The 'Global and Chinese Alpha-Ketoglutaric Acid Industry, 2012-2022 Market Research Report' is a professional and in-depth study on the current state of the global Alpha-Ketoglutaric Acid industry with a focus on the Chinese market. The report provides key statistics on the market status of the Alph...

Global and Chinese Alpha-Methylstyrene Industry, 2017 Market Research Report

Published Date : Oct 2017

The 'Global and Chinese Alpha-Methylstyrene Industry, 2012-2022 Market Research Report' is a professional and in-depth study on the current state of the global Alpha-Methylstyrene industry with a focus on the Chinese market. The report provides key statistics on the market status of the Alpha-Methyl...

Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Professional Survey Report 2017

Published Date : Oct 2017

This report studies Lysosomal Acid Lipase Deficiency (LAAL) Treatment in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This r...

Global Alpha-Cyclodextrin Sales Market Report 2017

Published Date : Oct 2017

In this report, the global Alpha-Cyclodextrin market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K MT), reve...

Global Thioctic Acid (Alpha Lipoic Acid) Market Professional Survey Report 2017

Published Date : Oct 2017

This report studies Thioctic Acid (Alpha Lipoic Acid) in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on...

Global alpha-Phellandrene (CAS 99-83-2) Market Professional Survey Report 2017

Published Date : Oct 2017

This report studies alpha-Phellandrene (CAS 99-83-2) in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on ...

 

Select License :

  • Single User : $4500
  • Multiple User : $7000
  • Corporate User : $10000

Happy To Assist You

Assist you at Worldwide Market Reports

We will be happy to help you find what you need. Please call us or write to us:

Worldwide Market Reports Benefits

Custom Research Solution

Talk to our research consultant to design an exclusive report as per your research needs.

Customer Fulfilment

We aim to fulfil client's research demands with tailored research solutions.

Quick Turnaround Time Reports

We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

360-degree Approach

We cover each industry from supply and demand side with an aim to provide a most holistic research study.